Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
about
Disease-modifying therapeutic directions for Lewy-Body dementiasA progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") miceCharacterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectorsToxin-Induced Experimental Models of Learning and Memory ImpairmentLate-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging.The neurobiological basis of cognitive impairment in Parkinson's disease.Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneuronsSoluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia.α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.Fasudil attenuates aggregation of α-synuclein in models of Parkinson's diseaseRodent models of Parkinson's disease: beyond the motor symptomatologyA Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic miceBasal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.Non-motor features of Parkinson disease.α-synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease.Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability.Impaired baroreflex function in mice overexpressing alpha-synuclein.The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells.Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B.A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein.Locomotor differences in mice expressing wild-type human α-synuclein.
P2860
Q26782907-04BDC1C0-2BB6-455A-8824-AEA89727457AQ26859072-9B98D4F8-F315-44BF-9B27-BB044FCF069CQ27318127-29701DBB-BEB2-4A51-BFD8-F1A013DE14FBQ28075913-FCD6EA76-132D-4F06-9E9B-0E29822EF40CQ31032932-C036508B-64E6-49E2-985D-62AB04B1C230Q33724698-8D41ABD0-2E96-4404-82F6-9B44C05BEB0AQ33856698-75AEEFBF-73AD-408B-AA90-B688333CA882Q36182604-7EAC62C4-440B-4EE7-BA65-8DE566C24D58Q36410380-4B9513DD-18BC-4C42-9CDF-B5DE93F93C44Q36608855-D925485B-4755-4E6C-B1F8-F0A3034A1D63Q36825541-B1A1A44D-8271-4A81-9286-D9F6CC939FFEQ37343565-5732687B-D9EE-4147-ABE1-F6321010E21CQ38741513-B1B843BA-4A70-4AF3-8892-289B52D15A27Q38795375-6CC3739A-5EE7-4AF5-9B31-98A28B07B4BDQ38961546-427C2D95-B186-47B8-BD48-BA81802D765EQ39358549-2D37A820-510D-44B1-A481-19947FAE198DQ41117719-9649F19F-40D3-4DE5-B6CE-0086D139AD62Q41493407-4F617710-07FE-4780-81EB-8577DE7CCF81Q41837152-A6D68788-DD37-4D73-93EC-CB8925A7698AQ45931909-566F5CEC-8CCA-461C-A74B-78EA8D10F548Q46047010-3B89A9D1-6D81-454A-ACE7-D874890F49FCQ46301248-0246AE4D-937B-4BF9-A77E-579EA2119093Q47548619-3D80F2DD-62A7-427F-8954-1E9F1F00490FQ48104086-1A9CCF76-1DD5-44B0-AEFA-7D4A3CAA6688Q51767457-925964A7-95CE-4CEA-A312-4D4118F9C50C
P2860
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
@en
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease.
@nl
type
label
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
@en
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease.
@nl
prefLabel
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
@en
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease.
@nl
P2093
P2860
P50
P1476
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
@en
P2093
Chunni Zhu
Diana Dinh
Eddie C Garcia
Eileen Ruth Torres
Iddo Magen
Katherine M Cardiff
Krystal De La Rosa
Maria Sanchez
Sheila M Fleming
P2860
P304
P356
10.1111/J.1460-9568.2012.08012.X
P407
P577
2012-02-22T00:00:00Z